Influence of physician networks on prescribing a new ingredient combination in heart failure: a longitudinal claim data-based study

Background Since 2016, the combination of sacubitril/valsartan, which combines an angiotensin receptor and neprilysin inhibitor (ARNI), has been recommended in the guidelines for the treatment of heart failure. The adoption of new drugs may be influenced by collaboration and exchange between physici...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Arnold, Christine (VerfasserIn) , Koetsenruijter, Jan (VerfasserIn) , Forstner, Johanna (VerfasserIn) , Peters-Klimm, Frank (VerfasserIn) , Wensing, Michel (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 28 August 2021
In: Implementation science
Year: 2021, Jahrgang: 16, Pages: 1-10
ISSN:1748-5908
DOI:10.1186/s13012-021-01150-y
Online-Zugang:Verlag, kostenfrei, Volltext: https://doi.org/10.1186/s13012-021-01150-y
Verlag, kostenfrei: https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=DOISource&SrcApp=WOS&KeyAID=10.1186%2Fs13012-021-01150-y&DestApp=DOI&SrcAppSID=D5uIu7JVch6JSwjtsIG&SrcJTitle=IMPLEMENTATION+SCIENCE&DestDOIRegistrantName=Springer+%28Biomed+Central+Ltd.%29
Volltext
Verfasserangaben:Christine Arnold, Jan Koetsenruijter, Johanna Forstner, Frank Peters-Klimm and Michel Wensing

MARC

LEADER 00000caa a2200000 c 4500
001 1771844353
003 DE-627
005 20230427160050.0
007 cr uuu---uuuuu
008 210927s2021 xx |||||o 00| ||eng c
024 7 |a 10.1186/s13012-021-01150-y  |2 doi 
035 |a (DE-627)1771844353 
035 |a (DE-599)KXP1771844353 
035 |a (OCoLC)1341421553 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Arnold, Christine  |d 1986-  |e VerfasserIn  |0 (DE-588)1198963557  |0 (DE-627)1681179083  |4 aut 
245 1 0 |a Influence of physician networks on prescribing a new ingredient combination in heart failure  |b a longitudinal claim data-based study  |c Christine Arnold, Jan Koetsenruijter, Johanna Forstner, Frank Peters-Klimm and Michel Wensing 
264 1 |c 28 August 2021 
300 |a 10 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 27.09.2021 
520 |a Background Since 2016, the combination of sacubitril/valsartan, which combines an angiotensin receptor and neprilysin inhibitor (ARNI), has been recommended in the guidelines for the treatment of heart failure. The adoption of new drugs may be influenced by collaboration and exchange between physicians. We aimed to determine whether characteristics of the professional networks of prescribing physicians were associated with the prescribing of ARNI in Germany. Methods We conducted a longitudinal analysis based on claims data in 2016-2018 in Germany. The characteristics of ambulatory care physicians' networks were determined in the analysis of the patient-sharing networks of physicians in 2017. Binary logistic regression analysis with the outcome 'prescribes ARNI in 2018' (present or absent) was carried out, using network characteristics as predictors, adjusted for specialty and sociodemographic characteristics of physicians. Results The network analysis included 8370 physicians, who had 144,636 connections. Prescribers had more connections to other physicians compared to non-prescribers (median 31 vs. 23). Regression analysis showed that the numbers of linkages to prescribers of ARNI were positively associated with prescribing ARNI. For 6-10 connections, the average marginal effect (AME) was 0.04 (confidence interval [CI] 95% 0.01-0.06) and for > 10 links the AME 0.07 (CI 95% 0.05-0.10) compared to 0-5 connections to prescriber. Conclusion Physicians who shared patients with many other physicians were more likely to prescribe ARNI, independent of physicians' specialty. This suggested that collaboration and exchange on the basis of patient-sharing with other physicians influenced their medication prescribing decisions. 
650 4 |a adoption 
650 4 |a Ambulatory care 
650 4 |a Chronic heart failure 
650 4 |a diffusion 
650 4 |a guidelines 
650 4 |a Implementation science 
650 4 |a innovation 
650 4 |a Medication prescribing 
650 4 |a Social network analysis 
700 1 |a Koetsenruijter, Jan  |e VerfasserIn  |0 (DE-588)120088289X  |0 (DE-627)1683882121  |4 aut 
700 1 |a Forstner, Johanna  |d 1991-  |e VerfasserIn  |0 (DE-588)1133290485  |0 (DE-627)889089620  |0 (DE-576)489225616  |4 aut 
700 1 |a Peters-Klimm, Frank  |d 1970-  |e VerfasserIn  |0 (DE-588)1049160819  |0 (DE-627)781265215  |0 (DE-576)348126530  |4 aut 
700 1 |a Wensing, Michel  |d 1967-  |e VerfasserIn  |0 (DE-588)173088341  |0 (DE-627)698011937  |0 (DE-576)13394042X  |4 aut 
773 0 8 |i Enthalten in  |t Implementation science  |d London : BioMed Central, 2006  |g 16(2021), Artikel-ID 84, Seite 1-10  |h Online-Ressource  |w (DE-627)509006191  |w (DE-600)2225822-X  |w (DE-576)260590053  |x 1748-5908  |7 nnas  |a Influence of physician networks on prescribing a new ingredient combination in heart failure a longitudinal claim data-based study 
773 1 8 |g volume:16  |g year:2021  |g elocationid:84  |g pages:1-10  |g extent:10  |a Influence of physician networks on prescribing a new ingredient combination in heart failure a longitudinal claim data-based study 
856 4 0 |u https://doi.org/10.1186/s13012-021-01150-y  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcAuth=DOISource&SrcApp=WOS&KeyAID=10.1186%2Fs13012-021-01150-y&DestApp=DOI&SrcAppSID=D5uIu7JVch6JSwjtsIG&SrcJTitle=IMPLEMENTATION+SCIENCE&DestDOIRegistrantName=Springer+%28Biomed+Central+Ltd.%29  |x Verlag  |z kostenfrei 
951 |a AR 
992 |a 20210927 
993 |a Article 
994 |a 2021 
998 |g 173088341  |a Wensing, Michel  |m 173088341:Wensing, Michel  |d 910000  |d 910100  |e 910000PW173088341  |e 910100PW173088341  |k 0/910000/  |k 1/910000/910100/  |p 5  |y j 
998 |g 1049160819  |a Peters-Klimm, Frank  |m 1049160819:Peters-Klimm, Frank  |d 910000  |d 910100  |e 910000PP1049160819  |e 910100PP1049160819  |k 0/910000/  |k 1/910000/910100/  |p 4 
998 |g 1133290485  |a Forstner, Johanna  |m 1133290485:Forstner, Johanna  |d 910000  |d 910100  |e 910000PF1133290485  |e 910100PF1133290485  |k 0/910000/  |k 1/910000/910100/  |p 3 
998 |g 120088289X  |a Koetsenruijter, Jan  |m 120088289X:Koetsenruijter, Jan  |d 910000  |d 910100  |e 910000PK120088289X  |e 910100PK120088289X  |k 0/910000/  |k 1/910000/910100/  |p 2 
998 |g 1198963557  |a Arnold, Christine  |m 1198963557:Arnold, Christine  |d 910000  |d 910100  |e 910000PA1198963557  |e 910100PA1198963557  |k 0/910000/  |k 1/910000/910100/  |p 1  |x j 
999 |a KXP-PPN1771844353  |e 3981512723 
BIB |a Y 
SER |a journal 
JSO |a {"recId":"1771844353","note":["Gesehen am 27.09.2021"],"name":{"displayForm":["Christine Arnold, Jan Koetsenruijter, Johanna Forstner, Frank Peters-Klimm and Michel Wensing"]},"relHost":[{"disp":"Influence of physician networks on prescribing a new ingredient combination in heart failure a longitudinal claim data-based studyImplementation science","pubHistory":["1.2006 -"],"recId":"509006191","id":{"zdb":["2225822-X"],"issn":["1748-5908"],"eki":["509006191"]},"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedDisp":"2006-","publisherPlace":"London","publisher":"BioMed Central","dateIssuedKey":"2006"}],"part":{"year":"2021","extent":"10","volume":"16","pages":"1-10","text":"16(2021), Artikel-ID 84, Seite 1-10"},"physDesc":[{"extent":"Online-Ressource"}],"title":[{"title_sort":"Implementation science","title":"Implementation science"}]}],"physDesc":[{"extent":"10 S."}],"person":[{"role":"aut","given":"Christine","display":"Arnold, Christine","family":"Arnold"},{"family":"Koetsenruijter","display":"Koetsenruijter, Jan","given":"Jan","role":"aut"},{"given":"Johanna","display":"Forstner, Johanna","family":"Forstner","role":"aut"},{"role":"aut","given":"Frank","display":"Peters-Klimm, Frank","family":"Peters-Klimm"},{"given":"Michel","family":"Wensing","display":"Wensing, Michel","role":"aut"}],"title":[{"title_sort":"Influence of physician networks on prescribing a new ingredient combination in heart failure","title":"Influence of physician networks on prescribing a new ingredient combination in heart failure","subtitle":"a longitudinal claim data-based study"}],"id":{"eki":["1771844353"],"doi":["10.1186/s13012-021-01150-y"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"origin":[{"dateIssuedDisp":"28 August 2021","dateIssuedKey":"2021"}]} 
SRT |a ARNOLDCHRIINFLUENCEO2820